Sodium Channel Blockers - Global Market insights and Sales Trends 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Sodium Channel Blockers - Global Market insights and Sales Trends 2024
Sodium Channel Blockers are a class of drugs that selectively block sodium channels and inhibit the influx of sodium ions. The degree of drug blocking of sodium channels is related to heart rate, membrane potential of cardiomyocytes and the reactivation time constant of the channel.
Global Sodium Channel Blockers market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2029. Demand from Injection and Oral are the major drivers for the industry."&
North America, Europe and Asia Pacific are the key regions for Sodium Channel Blockers industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2029.
Globally, Sodium Channel Blockers key manufacturers include SK biopharmaceuticals, Biogen, Parion Sciences, AlphaNavi Pharma, WEX, Vertex Pharmaceuticals, RaQualia Pharma and KBP Biosciences, etc. SK biopharmaceuticals, Biogen, Parion Sciences are top 3 players and held % sales share in total in 2022.
Sodium Channel Blockers can be divided into Class IA (Quinidine, Procainamide, etc.), Class IB (Lidocaine, Phenytoin, Mexiletine, etc.) and Class IC (Propafenone, Flecainide, etc.),, etc. Class IA (Quinidine, Procainamide, etc.) is the mainstream product in the market, accounting for % sales share globally in 2022.
Sodium Channel Blockers is widely used in various fields, such as Injection, Oral and Others,, etc. Injection provides greatest supports to the Sodium Channel Blockers industry development. In 2022, global % sales of Sodium Channel Blockers went into Injection filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Sodium Channel Blockers market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
SK biopharmaceuticals
Biogen
Parion Sciences
AlphaNavi Pharma
WEX
Vertex Pharmaceuticals
RaQualia Pharma
KBP Biosciences
Segment by Type
Class IA (Quinidine, Procainamide, etc.)
Class IB (Lidocaine, Phenytoin, Mexiletine, etc.)
Class IC (Propafenone, Flecainide, etc.)
Injection
Oral
Others
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Sodium Channel Blockers market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Sodium Channel Blockers, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Sodium Channel Blockers industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Sodium Channel Blockers in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Sodium Channel Blockers introduction, etc. Sodium Channel Blockers Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Sodium Channel Blockers market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Global Sodium Channel Blockers market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2029. Demand from Injection and Oral are the major drivers for the industry."&
North America, Europe and Asia Pacific are the key regions for Sodium Channel Blockers industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2029.
Globally, Sodium Channel Blockers key manufacturers include SK biopharmaceuticals, Biogen, Parion Sciences, AlphaNavi Pharma, WEX, Vertex Pharmaceuticals, RaQualia Pharma and KBP Biosciences, etc. SK biopharmaceuticals, Biogen, Parion Sciences are top 3 players and held % sales share in total in 2022.
Sodium Channel Blockers can be divided into Class IA (Quinidine, Procainamide, etc.), Class IB (Lidocaine, Phenytoin, Mexiletine, etc.) and Class IC (Propafenone, Flecainide, etc.),, etc. Class IA (Quinidine, Procainamide, etc.) is the mainstream product in the market, accounting for % sales share globally in 2022.
Sodium Channel Blockers is widely used in various fields, such as Injection, Oral and Others,, etc. Injection provides greatest supports to the Sodium Channel Blockers industry development. In 2022, global % sales of Sodium Channel Blockers went into Injection filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Sodium Channel Blockers market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
SK biopharmaceuticals
Biogen
Parion Sciences
AlphaNavi Pharma
WEX
Vertex Pharmaceuticals
RaQualia Pharma
KBP Biosciences
Segment by Type
Class IA (Quinidine, Procainamide, etc.)
Class IB (Lidocaine, Phenytoin, Mexiletine, etc.)
Class IC (Propafenone, Flecainide, etc.)
Segment by Application
Injection
Oral
Others
Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Sodium Channel Blockers market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Sodium Channel Blockers, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Sodium Channel Blockers industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Sodium Channel Blockers in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Sodium Channel Blockers introduction, etc. Sodium Channel Blockers Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Sodium Channel Blockers market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices